LEBRIKIZUMAB-LBKZ for Dermatitis atopic: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 312 adverse event reports in the FDA FAERS database where LEBRIKIZUMAB-LBKZ was used for Dermatitis atopic.
Most Reported Side Effects for LEBRIKIZUMAB-LBKZ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 89 | 12.3% | 0 | 1 |
| Conjunctivitis | 51 | 7.0% | 0 | 0 |
| Rash | 50 | 6.9% | 0 | 0 |
| Pruritus | 47 | 6.5% | 0 | 1 |
| Eczema | 39 | 5.4% | 0 | 1 |
| Drug ineffective | 36 | 5.0% | 0 | 0 |
| Erythema | 34 | 4.7% | 0 | 1 |
| Dermatitis atopic | 32 | 4.4% | 0 | 3 |
| Urticaria | 25 | 3.4% | 0 | 1 |
| Hypersensitivity | 23 | 3.2% | 0 | 2 |
| Underdose | 22 | 3.0% | 0 | 0 |
| Condition aggravated | 19 | 2.6% | 0 | 0 |
| Eye pruritus | 18 | 2.5% | 0 | 0 |
| Ocular hyperaemia | 18 | 2.5% | 0 | 0 |
| Eye irritation | 16 | 2.2% | 0 | 0 |
Other Indications for LEBRIKIZUMAB-LBKZ
Other Drugs Used for Dermatitis atopic
DUPILUMAB (179,563)
UPADACITINIB (5,263)
TRALOKINUMAB-LDRM (3,007)
CRISABOROLE (2,139)
ABROCITINIB (1,616)
NEMOLIZUMAB-ILTO (1,596)
RUXOLITINIB (740)
TACROLIMUS (515)
METHOTREXATE (400)
CYCLOSPORINE (370)